# Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

> **NCT03388619** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Cancer Of Prostate
- Prostate Neoplasms
- Prostate Cancer
- Neoplasms of Prostate
- Prostatic Cancer

## Interventions

- **RADIATION:** Prostate bed with integrated boost
- **RADIATION:** Prostate bed irradiation only
- **DIAGNOSTIC_TEST:** Whole Body Bone Scan
- **DIAGNOSTIC_TEST:** 18F-NaF PET Imaging
- **DIAGNOSTIC_TEST:** CT
- **DIAGNOSTIC_TEST:** mpMRI
- **DRUG:** ADT

## Key facts

- **NCT ID:** NCT03388619
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-17
- **Primary completion:** 2023-12-29
- **Final completion:** 2025-12-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388619, "Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03388619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*